Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,002 public trials 1,838 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, not recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View all 34 locations
View Trial Details
Active, not recruiting

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

NCT03598998

Conditions
Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Active, not recruiting

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

NCT00846742

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Packard Children's Hospital, Stanford University Palo Alto, California, United States
  • Rady Children's Hospital- San Diego San Diego, California, United States
  • Children's Hospital of Illinois at OSF St. Francis Medical Center Peoria, Illinois, United States
  • Maine Children's Cancer Program (MCCP) Scarborough, Maine, United States
View Trial Details
Active, not recruiting

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

NCT04628494

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Community Health Network Cancer Center North Indianapolis, Indiana, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
  • Henry Ford Health System Jackson, Michigan, United States
View all 186 locations
View Trial Details
Active, not recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • UC Health Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

NCT04802590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • Universite Libre de Bruxelles - Hopital ERASME Brussels, Belgium
  • Hopital Jolimont Haine-Saint-Paul, Belgium
  • CHU de Liege Liège, Belgium
View all 45 locations
View Trial Details

Related conditions